Growth Hormones with Prolonged In-Vivo Efficacy
- 专利权人:
- Novo Nordisk HealthCare AG
- 发明人:
- Henrik Sune Andersen,Nils Langeland Johansen,Jens Buchardt,Leif Noerskov-Lauritsen
- 申请号：
- US15845072
- 公开号：
- US20180221501A1
- 申请日:
- 2017.12.18
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to polypeptide compound optimized for subcutaneous administration, exemplified by growth hormone conjugates having a linker providing non-covalent binding to albumin.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION AND BIOLOGICAL MATERIAL CONTAINING A FUSION PEPTIDE CONTAINING A BRAODYROID HORMONE (PTH) TO A BRAEL WORK SELECTION PEPTIDE
- Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
- GHRELIN MIMETIC POLYPEPTIDE HAPTEN IMMUNOCONJUGATES HAVING IMPROVED SOLUBILITY AND IMMUNOGENICITY AND METHODS OF USE THEREOF
- Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
- materials, systems, organisms and methods to increase abiotic stress tolerance, increase biomass and / or alter lignin composition
